Bank of America’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$159K Sell
19,157
-3,248
-14% -$27K ﹤0.01% 5329
2025
Q1
$136K Sell
22,405
-13,422
-37% -$81.7K ﹤0.01% 5376
2024
Q4
$226K Buy
35,827
+8,703
+32% +$55K ﹤0.01% 5196
2024
Q3
$136K Buy
27,124
+686
+3% +$3.43K ﹤0.01% 5331
2024
Q2
$162K Buy
26,438
+9,959
+60% +$60.9K ﹤0.01% 5188
2024
Q1
$183K Sell
16,479
-23,576
-59% -$262K ﹤0.01% 5089
2023
Q4
$449K Buy
40,055
+8,318
+26% +$93.3K ﹤0.01% 4692
2023
Q3
$238K Buy
31,737
+8,905
+39% +$66.9K ﹤0.01% 4939
2023
Q2
$202K Buy
22,832
+16,097
+239% +$142K ﹤0.01% 4995
2023
Q1
$56K Buy
6,735
+4,535
+206% +$37.7K ﹤0.01% 5663
2022
Q4
$21.1K Sell
2,200
-420
-16% -$4.03K ﹤0.01% 5923
2022
Q3
$21K Sell
2,620
-2,341
-47% -$18.8K ﹤0.01% 6151
2022
Q2
$28K Hold
4,961
﹤0.01% 6258
2022
Q1
$28K Sell
4,961
-6,422
-56% -$36.2K ﹤0.01% 6589
2021
Q4
$51K Buy
11,383
+6,536
+135% +$29.3K ﹤0.01% 6356
2021
Q3
$45K Buy
4,847
+392
+9% +$3.64K ﹤0.01% 6204
2021
Q2
$32K Sell
4,455
-29,152
-87% -$209K ﹤0.01% 6173
2021
Q1
$209K Buy
33,607
+13,397
+66% +$83.3K ﹤0.01% 5348
2020
Q4
$150K Sell
20,210
-493
-2% -$3.66K ﹤0.01% 5047
2020
Q3
$125K Sell
20,703
-15,851
-43% -$95.7K ﹤0.01% 4950
2020
Q2
$305K Buy
36,554
+27,882
+322% +$233K ﹤0.01% 4451
2020
Q1
$52K Buy
+8,672
New +$52K ﹤0.01% 5262
2019
Q3
Sell
-9,098
Closed -$36K 6442
2019
Q2
$36K Buy
9,098
+6,663
+274% +$26.4K ﹤0.01% 5636
2019
Q1
$11K Sell
2,435
-4,353
-64% -$19.7K ﹤0.01% 5851
2018
Q4
$44K Buy
6,788
+4,560
+205% +$29.6K ﹤0.01% 5499
2018
Q3
$19K Buy
2,228
+679
+44% +$5.79K ﹤0.01% 5772
2018
Q2
$16K Sell
1,549
-9,583
-86% -$99K ﹤0.01% 5821
2018
Q1
$135K Buy
+11,132
New +$135K ﹤0.01% 4863